 |
PDBsum entry 1dto
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Viral protein
|
PDB id
|
|
|
|
1dto
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Viral protein
|
 |
|
Title:
|
 |
Crystal structure of the complete transactivation domain of e2 protein from the human papillomavirus type 16
|
|
Structure:
|
 |
Regulatory protein e2. Chain: a. Fragment: transactivation domain. Engineered: yes
|
|
Source:
|
 |
Human papillomavirus type 16. Organism_taxid: 333760. Expressed in: escherichia coli. Expression_system_taxid: 562.
|
|
Biol. unit:
|
 |
Dimer (from PDB file)
|
|
Resolution:
|
 |
|
1.90Å
|
R-factor:
|
0.236
|
R-free:
|
0.305
|
|
|
Authors:
|
 |
A.A.Antson,J.E.Burns,O.V.Moroz,D.J.Scott,C.M.Sanders,I.B.Bronstein, G.G.Dodson,K.S.Wilson,N.Maitland
|
Key ref:
|
 |
A.A.Antson
et al.
(2000).
Structure of the intact transactivation domain of the human papillomavirus E2 protein.
Nature,
403,
805-809.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
13-Jan-00
|
Release date:
|
23-Feb-00
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P03120
(VE2_HPV16) -
Regulatory protein E2 from Human papillomavirus type 16
|
|
|
|
Seq: Struc:
|
 |
 |
 |
365 a.a.
200 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Nature
403:805-809
(2000)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structure of the intact transactivation domain of the human papillomavirus E2 protein.
|
|
A.A.Antson,
J.E.Burns,
O.V.Moroz,
D.J.Scott,
C.M.Sanders,
I.B.Bronstein,
G.G.Dodson,
K.S.Wilson,
N.J.Maitland.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Papillomaviruses cause warts and proliferative lesions in skin and other
epithelia. In a minority of papillomavirus types ('high risk, including human
papillomaviruses 16, 18, 31, 33, 45 and 56), further transformation of the wart
lesions can produce tumours. The papillomavirus E2 protein controls primary
transcription and replication of the viral genome. Both activities are governed
by a approximately 200 amino-acid amino-terminal module (E2NT) which is
connected to a DNA-binding carboxy-terminal module by a flexible linker. Here we
describe the crystal structure of the complete E2NT module from human
papillomavirus 16. The E2NT module forms a dimer both in the crystal and in
solution. Amino acids that are necessary for transactivation are located at the
dimer interface, indicating that the dimer structure may be important in the
interactions of E2NT with viral and cellular transcription factors. We propose
that dimer formation may contribute to the stabilization of DNA loops which may
serve to relocate distal DNA-binding transcription factors to the site of human
papillomavirus transcription initiation.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Figure 1: Functional and structural assignments of
papillomavirus E2. View of the N-terminal, linker and
C-terminal modules indicating the known functions of each.
Amino-acid numbers that delimit the modules correspond to those
of HPV16 E2.
|
 |
Figure 3.
Figure 3: Structural features of E2. a, Stereo view of the
electron density with the final model, at the dimer interface of
the E2NT module, viewed down the crystallographic twofold axis.
The likelihood weighted 2|F[o]|-| F[c]| electron density map is
contoured at the 1.5 level.
Ribbons of two independent monomers are shown in aquamarine and
yellow. Side chains of Arg 37 and Ile 73, which are known to be
critical for transactivation2, 10, are shown in dark green; side
chains of other residues at the dimer interface are shown in
light green. Oxygen atoms are in red, nitrogen atoms in blue;
water molecules are shown as orange spheres and hydrogen bonds
as dashed sticks. b, Stereo ribbon diagram of the E2NT dimer,
showing the extent of the interface between the two subunits.
The view is as in a but rotated clockwise by 90 °. Side chains
of Gln 12 and Glu 39 that are critical for interactions with E1
(refs 2,10,18) are shown in magenta. Side chains of residues at
the dimer interface are coloured as in a.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Macmillan Publishers Ltd:
Nature
(2000,
403,
805-809)
copyright 2000.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
W.Wang,
Y.Fang,
N.Sima,
Y.Li,
W.Li,
L.Li,
L.Han,
S.Liao,
Z.Han,
Q.Gao,
K.Li,
D.Deng,
L.Meng,
J.Zhou,
S.Wang,
and
D.Ma
(2011).
Triggering of death receptor apoptotic signaling by human papillomavirus 16 E2 protein in cervical cancer cell lines is mediated by interaction with c-FLIP.
|
| |
Apoptosis,
16,
55-66.
|
 |
|
|
|
|
 |
S.Aras,
G.Singh,
K.Johnston,
T.Foster,
and
A.Aiyar
(2009).
Zinc coordination is required for and regulates transcription activation by Epstein-Barr nuclear antigen 1.
|
| |
PLoS Pathog,
5,
e1000469.
|
 |
|
|
|
|
 |
S.Bodaghi,
R.Jia,
and
Z.M.Zheng
(2009).
Human papillomavirus type 16 E2 and E6 are RNA-binding proteins and inhibit in vitro splicing of pre-mRNAs with suboptimal splice sites.
|
| |
Virology,
386,
32-43.
|
 |
|
|
|
|
 |
E.E.Hernandez-Ramon,
J.E.Burns,
W.Zhang,
H.F.Walker,
S.Allen,
A.A.Antson,
and
N.J.Maitland
(2008).
Dimerization of the human papillomavirus type 16 E2 N terminus results in DNA looping within the upstream regulatory region.
|
| |
J Virol,
82,
4853-4861.
|
 |
|
|
|
|
 |
F.Thierry,
and
C.Demeret
(2008).
Direct activation of caspase 8 by the proapoptotic E2 protein of HPV18 independent of adaptor proteins.
|
| |
Cell Death Differ,
15,
1356-1363.
|
 |
|
|
|
|
 |
J.Cardenas-Mora,
J.E.Spindler,
M.K.Jang,
and
A.A.McBride
(2008).
Dimerization of the papillomavirus E2 protein is required for efficient mitotic chromosome association and Brd4 binding.
|
| |
J Virol,
82,
7298-7305.
|
 |
|
|
|
|
 |
J.Sim,
S.Ozgur,
B.Y.Lin,
J.H.Yu,
T.R.Broker,
L.T.Chow,
and
J.Griffith
(2008).
Remodeling of the human papillomavirus type 11 replication origin into discrete nucleoprotein particles and looped structures by the E2 protein.
|
| |
J Mol Biol,
375,
1165-1177.
|
 |
|
|
|
|
 |
C.M.Sanders,
D.Sizov,
P.R.Seavers,
M.Ortiz-Lombardía,
and
A.A.Antson
(2007).
Transcription activator structure reveals redox control of a replication initiation reaction.
|
| |
Nucleic Acids Res,
35,
3504-3515.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
C.M.Hebner,
and
L.A.Laimins
(2006).
Human papillomaviruses: basic mechanisms of pathogenesis and oncogenicity.
|
| |
Rev Med Virol,
16,
83-97.
|
 |
|
|
|
|
 |
E.A.Abbate,
C.Voitenleitner,
and
M.R.Botchan
(2006).
Structure of the papillomavirus DNA-tethering complex E2:Brd4 and a peptide that ablates HPV chromosomal association.
|
| |
Mol Cell,
24,
877-889.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
E.Hooley,
V.Fairweather,
A.R.Clarke,
K.Gaston,
and
R.L.Brady
(2006).
The recognition of local DNA conformation by the human papillomavirus type 6 E2 protein.
|
| |
Nucleic Acids Res,
34,
3897-3908.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
M.R.Schweiger,
J.You,
and
P.M.Howley
(2006).
Bromodomain protein 4 mediates the papillomavirus E2 transcriptional activation function.
|
| |
J Virol,
80,
4276-4285.
|
 |
|
|
|
|
 |
Y.W.Tan,
S.Fang,
H.Fan,
J.Lescar,
and
D.X.Liu
(2006).
Amino acid residues critical for RNA-binding in the N-terminal domain of the nucleocapsid protein are essential determinants for the infectivity of coronavirus in cultured cells.
|
| |
Nucleic Acids Res,
34,
4816-4825.
|
 |
|
|
|
|
 |
M.K.Baxter,
and
A.A.McBride
(2005).
An acidic amphipathic helix in the Bovine Papillomavirus E2 protein is critical for DNA replication and interaction with the E1 protein.
|
| |
Virology,
332,
78-88.
|
 |
|
|
|
|
 |
M.K.Baxter,
M.G.McPhillips,
K.Ozato,
and
A.A.McBride
(2005).
The mitotic chromosome binding activity of the papillomavirus E2 protein correlates with interaction with the cellular chromosomal protein, Brd4.
|
| |
J Virol,
79,
4806-4818.
|
 |
|
|
|
|
 |
P.S.Zheng,
J.Brokaw,
and
A.A.McBride
(2005).
Conditional mutations in the mitotic chromosome binding function of the bovine papillomavirus type 1 E2 protein.
|
| |
J Virol,
79,
1500-1509.
|
 |
|
|
|
|
 |
S.Blachon,
S.Bellanger,
C.Demeret,
and
F.Thierry
(2005).
Nucleo-cytoplasmic shuttling of high risk human Papillomavirus E2 proteins induces apoptosis.
|
| |
J Biol Chem,
280,
36088-36098.
|
 |
|
|
|
|
 |
A.Abroi,
I.Ilves,
S.Kivi,
and
M.Ustav
(2004).
Analysis of chromatin attachment and partitioning functions of bovine papillomavirus type 1 E2 protein.
|
| |
J Virol,
78,
2100-2113.
|
 |
|
|
|
|
 |
E.A.Abbate,
J.M.Berger,
and
M.R.Botchan
(2004).
The X-ray structure of the papillomavirus helicase in complex with its molecular matchmaker E2.
|
| |
Genes Dev,
18,
1981-1996.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
L.M.Lima,
and
J.L.Silva
(2004).
Positive contribution of hydration on DNA binding by E2c protein from papillomavirus.
|
| |
J Biol Chem,
279,
47968-47974.
|
 |
|
|
|
|
 |
M.S.Longworth,
and
L.A.Laimins
(2004).
Pathogenesis of human papillomaviruses in differentiating epithelia.
|
| |
Microbiol Mol Biol Rev,
68,
362-372.
|
 |
|
|
|
|
 |
Y.Wang,
R.Coulombe,
D.R.Cameron,
L.Thauvette,
M.J.Massariol,
L.M.Amon,
D.Fink,
S.Titolo,
E.Welchner,
C.Yoakim,
J.Archambault,
and
P.W.White
(2004).
Crystal structure of the E2 transactivation domain of human papillomavirus type 11 bound to a protein interaction inhibitor.
|
| |
J Biol Chem,
279,
6976-6985.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
P.W.White,
S.Titolo,
K.Brault,
L.Thauvette,
A.Pelletier,
E.Welchner,
L.Bourgon,
L.Doyon,
W.W.Ogilvie,
C.Yoakim,
M.G.Cordingley,
and
J.Archambault
(2003).
Inhibition of human papillomavirus DNA replication by small molecule antagonists of the E1-E2 protein interaction.
|
| |
J Biol Chem,
278,
26765-26772.
|
 |
|
|
|
|
 |
R.S.Hegde
(2002).
The papillomavirus E2 proteins: structure, function, and biology.
|
| |
Annu Rev Biophys Biomol Struct,
31,
343-360.
|
 |
|
|
|
|
 |
S.Noubir,
I.Luque,
J.A.Ochoa de Alda,
I.Perewoska,
N.Tandeau de Marsac,
J.G.Cobley,
and
J.Houmard
(2002).
Co-ordinated expression of phycobiliprotein operons in the chromatically adapting cyanobacterium Calothrix PCC 7601: a role for RcaD and RcaG.
|
| |
Mol Microbiol,
43,
749-762.
|
 |
|
|
|
|
 |
S.Y.Hou,
S.Y.Wu,
and
C.M.Chiang
(2002).
Transcriptional activity among high and low risk human papillomavirus E2 proteins correlates with E2 DNA binding.
|
| |
J Biol Chem,
277,
45619-45629.
|
 |
|
|
|
|
 |
W.Boner,
E.R.Taylor,
E.Tsirimonaki,
K.Yamane,
M.S.Campo,
and
I.M.Morgan
(2002).
A Functional interaction between the human papillomavirus 16 transcription/replication factor E2 and the DNA damage response protein TopBP1.
|
| |
J Biol Chem,
277,
22297-22303.
|
 |
|
|
|
|
 |
F.X.Wilson
(2001).
Emerging therapies for human papillomavirus infection.
|
| |
Expert Opin Emerg Drugs,
6,
199-207.
|
 |
|
|
|
|
 |
J.L.Beck,
M.L.Colgrave,
S.F.Ralph,
and
M.M.Sheil
(2001).
Electrospray ionization mass spectrometry of oligonucleotide complexes with drugs, metals, and proteins.
|
| |
Mass Spectrom Rev,
20,
61-87.
|
 |
|
|
|
|
 |
S.Bellanger,
C.Demeret,
S.Goyat,
and
F.Thierry
(2001).
Stability of the human papillomavirus type 18 E2 protein is regulated by a proteasome degradation pathway through its amino-terminal transactivation domain.
|
| |
J Virol,
75,
7244-7251.
|
 |
|
|
|
|
 |
K.A.Alexander,
and
W.C.Phelps
(2000).
Recent advances in diagnosis and therapy of human papillomaviruses.
|
| |
Expert Opin Investig Drugs,
9,
1753-1765.
|
 |
|
|
|
|
 |
L.M.Lima,
D.Foguel,
and
J.L.Silva
(2000).
DNA tightens the dimeric DNA-binding domain of human papillomavirus E2 protein without changes in volume.
|
| |
Proc Natl Acad Sci U S A,
97,
14289-14294.
|
 |
|
|
|
|
 |
Y.C.Peng,
D.E.Breiding,
F.Sverdrup,
J.Richard,
and
E.J.Androphy
(2000).
AMF-1/Gps2 binds p300 and enhances its interaction with papillomavirus E2 proteins.
|
| |
J Virol,
74,
5872-5879.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |